Isoxazolopyrimidines as novel F508-CFTR correctors

Gui Jun Yu, Baoxue Yang, A. S. Verkman, Mark J. Kurth

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Using a cell-based high-throughput screen, we identified isoxazolo[5,4-d]pyrimidines as novel small-molecule correctors of the cystic fibrosis mutant protein F508-CFTR. 22 Isoxazolo[5,4-d]pyrimidine analogues were synthesized and tested. Synthesis of the key intermediate, 5-amino-3- arylisoxazole-4-carboxamide, was accomplished by nitrile oxide cycloaddition to (2-amino-1-cyano-2-oxoethyl)sodium. Formation of 3-arylisoxazolo-[5,4-d] pyrimidin-4(5H)-one and chlorination gave 4-chloro-3-arylisoxazolo[5,4-d] pyrimidine. Finally, functionalization at C-4 of the pyrimidine ring by nucleophilic substitution gave the targeted isoxazolo[5,4-d]pyrimidines. Six of the reported analogues had low micromolar potency for increasing halide transport in F508-CFTR cells.

Original languageEnglish (US)
Pages (from-to)1063-1066
Number of pages4
JournalSynlett
Issue number7
DOIs
StatePublished - 2010

Keywords

  • Corrector
  • Cystic fibrosis
  • F508-CFTR
  • Isoxazolopyrimidine

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint Dive into the research topics of 'Isoxazolopyrimidines as novel F508-CFTR correctors'. Together they form a unique fingerprint.

  • Cite this

    Yu, G. J., Yang, B., Verkman, A. S., & Kurth, M. J. (2010). Isoxazolopyrimidines as novel F508-CFTR correctors. Synlett, (7), 1063-1066. https://doi.org/10.1055/s-0029-1219781